DnB Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
1,731
-48
| -3% | -$6.6K | ﹤0.01% | 687 |
|
|
2025
Q1 | $321K | Buy |
1,779
+242
| +16% | +$43.6K | ﹤0.01% | 685 |
|
|
2024
Q4 | $241K | Sell |
1,537
-759
| -33% | -$119K | ﹤0.01% | 706 |
|
|
2024
Q3 | $418K | Sell |
2,296
-57
| -2% | -$10.4K | ﹤0.01% | 665 |
|
|
2024
Q2 | $432K | Buy |
2,353
+53
| +2% | +$9.74K | ﹤0.01% | 660 |
|
|
2024
Q1 | $409K | Buy |
+2,300
| New | +$409K | ﹤0.01% | 666 |
|
|
2022
Q2 | – | Sell |
-24,500
| Closed | -$1.63M | – | 661 |
|
|
2022
Q1 | $1.63M | Sell |
24,500
-11,140
| -31% | -$741K | 0.01% | 571 |
|
|
2021
Q4 | $2.49M | Buy |
+35,640
| New | +$2.49M | 0.01% | 521 |
|